This is Simulo, a companion device and application that allows patients at risk of developing cancer the ability to monitor their health in real time.
Over the course of a 10 week sprint, our team was prompted to explore how we may implement IoT and Digital Twin Technology in conjunction within an existing industry to solve problems in the near future.
When thinking about ways we could implement a preventative healthcare solution with emerging digital twin technology, we decided to focus on patients at risk of a cancer diagnosis. It was our goal to both provide patients with a solution that allows for the monitoring of a possible cancer diagnosis, and a solution that allows those who are undergoing remission to get real time updates about their test results.
To get a better idea of the current state of the healthcare space, we began our initial research with a series of online surveys, addressing both healthcare patients as well as healthcare professionals.
When conducting our initial surveys, we found that while 81% of patients stated that they do not use a healthcare device, 78% expressed interest in using them. This provided us with a tangible opportunity to explore, with regard to creating a healthcare device dedicated to the prevention of cancer.
In order to understand our primary audience: individuals diagnosed with cancer who have either achieved remission, or are going through treatment, we conducted several surveys and user interviews with individuals who are cancer survivors and individuals with a family history of cancer, who may be worried about their risk of disease.
We also interviewed healthcare providers, in order to understand the full cancer journey and the relationship between patient and provider. We wanted to gain insight on whether or not healthcare providers trusted wearable devices that monitor activity. It was important for us to understand the root of the anxiety patients feel when going to get their lab results, and why time was a large factor in that.
Our vision for early cancer detection resulted in designing around a sophisticated electronic sensor that has the ability to replicate the mammalian olfactory system. Research shows that cancer cells produce a unique smell that differs significantly from normal functioning cells. Thus, smell indicates the possibility of a cancerous growth, allowing for better control and direction of treatment for our users. The sensor nested within the Simulo unit is able to read the internal function of the human body through exhaled breath.